Concepedia

Extended Mycophenolate Mofetil Administration Beyond Day 30 in Allogeneic Hematopoietic Stem Cell Transplantation as Preemptive Therapy for Severe Graft-Versus-Host Disease

Sayaka Nishikawa, Atsuo Okamura, Miho Yamamori, Kentaro Minagawa, Yuriko Kawamori, Yuko Kawano, Hiroyuki Kawano, Kanako Ono, Yoshio Katayama, Manabu Shimoyama,

Transplantation Proceedings · 2009 · 17 citations · 15 references

DOI

Concepts

References

15

1994 Consensus Conference on Acute GVHD Grading.

Donna Przepiorka, Daniel Weisdorf, Peyton Martin et al. · PubMed · 1995 · 5.1K citations

, , +6

Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease

Claudio G. Brunstein, Juliet N. Barker, Daniel J. Weisdorf et al. · Blood · 2007 · 502 citations · Full text

, , +17

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

Brian J. Bolwell, Ronald Sobecks, Brad Pohlman et al. · Bone Marrow Transplantation · 2004 · 204 citations

, , +15

A Phase I/II Study of Mycophenolate Mofetil in Combination with Cyclosporine for Prophylaxis of Acute Graft-versus-Host Disease after Myeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation

Richard A. Nash, Laura Johnston, Pablo Parker et al. · Biology of Blood and Marrow Transplantation · 2005 · 124 citations

, , +14

A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients

Ifeyinwa Osunkwo, Olga Bessmertny, Lauren Harrison et al. · Biology of Blood and Marrow Transplantation · 2004 · 98 citations · Full text

, , +16